224 related articles for article (PubMed ID: 34452625)
1. The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer.
Fessart D; Robert J; Hartog C; Chevet E; Delom F; Babin G
J Exp Clin Cancer Res; 2021 Aug; 40(1):271. PubMed ID: 34452625
[TBL] [Abstract][Full Text] [Related]
2. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of serum and tissue AGR2 for diagnosis and prognosis in epithelial ovarian cancer.
Yan T; Wang H; Ma X; Cao J; Tong Y; Guo L; Lu R
Biomark Med; 2023 Mar; 17(6):325-336. PubMed ID: 37284743
[No Abstract] [Full Text] [Related]
4. The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer.
Liu CL; Yuan RH; Mao TL
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356623
[TBL] [Abstract][Full Text] [Related]
5. The role of AGR2 and AGR3 in cancer: similar but not identical.
Obacz J; Takacova M; Brychtova V; Dobes P; Pastorekova S; Vojtesek B; Hrstka R
Eur J Cell Biol; 2015; 94(3-4):139-47. PubMed ID: 25666661
[TBL] [Abstract][Full Text] [Related]
6. miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.
Nagaraj AB; Joseph P; DiFeo A
Biomark Med; 2015; 9(3):241-57. PubMed ID: 25731210
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer.
Saini A; Chandra KB; Kumar V; Mathur SR; Sharma JB; Kumar S; Yadav S
Mol Biol Rep; 2020 Dec; 47(12):9459-9468. PubMed ID: 33263168
[TBL] [Abstract][Full Text] [Related]
8. Loss of 4.1N in epithelial ovarian cancer results in EMT and matrix-detached cell death resistance.
Wang D; Zhang L; Hu A; Wang Y; Liu Y; Yang J; Du N; An X; Wu C; Liu C
Protein Cell; 2021 Feb; 12(2):107-127. PubMed ID: 32448967
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
10. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK
Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362
[TBL] [Abstract][Full Text] [Related]
11. Emerging Protein Biomarkers in Epithelial Ovarian Cancer Prognosis: An Aid for Multivariate Indexing.
Paliwal P; Ranade H; Desai D; Datta M
Curr Protein Pept Sci; 2021; 22(7):505-513. PubMed ID: 33568031
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
13. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.
Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y
J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
15. Prognostic biomarkers in ovarian cancer.
Huang J; Hu W; Sood AK
Cancer Biomark; 2010-2011; 8(4-5):231-51. PubMed ID: 22045356
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
Wang J; Zhao S; Wang F; Wang J; Zhang Y
Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
[TBL] [Abstract][Full Text] [Related]
17. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
[TBL] [Abstract][Full Text] [Related]
18. Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer.
Guo F; Feng L; Hu JL; Wang ML; Luo P; Zhong XM; Deng AM
Tumour Biol; 2015 Jan; 36(1):453-8. PubMed ID: 25270739
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.
Zeng Y; Chen M; Ganesh S; Hu S; Chen H
PLoS One; 2020; 15(5):e0232235. PubMed ID: 32401768
[TBL] [Abstract][Full Text] [Related]
20. The expression levels and clinical significance of MFG-E8 and CD133 in epithelial ovarian cancer.
Li N; Dai C; Yang Y; Wu X; Wang L; Wang P
Gynecol Endocrinol; 2020 Sep; 36(9):803-807. PubMed ID: 31899997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
